glp 1 drugs blindness Risk GLP-1 Weight Loss Drugs linked
Description
Secondary outcomes included changes in biochemical markers and adverse effects (AEs)
GLP-1 RA = glucagon-like peptide-1 receptor agonist
Accessed 24 Dec 2021
Biopsy revealed epidermal acanthosis and perivascular neutrophilic infiltrate
doi: 10.1016/j.jacc.2024.11.001 [DOI] [PubMed] [Google Scholar] 207.Wadden TA, Chao AM, Machineni S, et al
Subgroup analyses (Figure 5) (exploratory) revealed similar directional trends across subgroups, including patients with organ transplantation (HR 0.27, 95% CI 0.090.82
